company background image
C8R

Jiutian Chemical Group Catalist:C8R Stock Report

Last Price

S$0.094

Market Cap

S$186.9m

7D

-1.1%

1Y

9.3%

Updated

14 Aug, 2022

Data

Company Financials +
C8R fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance6/6
Financial Health5/6
Dividends4/6

C8R Stock Overview

Jiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People’s Republic of China.

Jiutian Chemical Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiutian Chemical Group
Historical stock prices
Current Share PriceS$0.094
52 Week HighS$0.11
52 Week LowS$0.067
Beta2.58
1 Month Change11.91%
3 Month Change-4.08%
1 Year Change9.30%
3 Year Change571.43%
5 Year Change213.33%
Change since IPO-33.80%

Recent News & Updates

Shareholder Returns

C8RSG ChemicalsSG Market
7D-1.1%6.2%-0.4%
1Y9.3%-49.5%-0.3%

Return vs Industry: C8R exceeded the SG Chemicals industry which returned -49.5% over the past year.

Return vs Market: C8R exceeded the SG Market which returned -0.3% over the past year.

Price Volatility

Is C8R's price volatile compared to industry and market?
C8R volatility
C8R Average Weekly Movement4.7%
Chemicals Industry Average Movement5.7%
Market Average Movement4.6%
10% most volatile stocks in SG Market12.5%
10% least volatile stocks in SG Market2.1%

Stable Share Price: C8R is not significantly more volatile than the rest of SG stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: C8R's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994n/aHongguang Weihttps://www.uxasite.com

Jiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People’s Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, pharmaceutical, and agro chemical products, as well as an absorbing agent primarily in electronics, acrylic fibers, and pharmaceutical products; and methylamine, a chemical feedstock in the organic chemical industry used in various areas, such as agricultural chemicals, medicines, fuels, synthetic resins, and leather making, as well as in the production of the solvent used for chemical fibers, activating agents, and photography. It also provides sodium hydrosulfite, a crystalline powder for use in water treatment, gas purification, cleaning, and stripping, as well as in the industrial processing of textiles, leather, foods, polymers, photography, and others; industrial and consumable carbon dioxide for use in aerated beverages, tobacco, and preserving vegetables; Oxygen-18, an isotope of oxygen to produce fluorodeoxyglucose; deuterium depleted water to inhibit cancer growth; and industrial methanol.

Jiutian Chemical Group Fundamentals Summary

How do Jiutian Chemical Group's earnings and revenue compare to its market cap?
C8R fundamental statistics
Market CapCN¥918.49m
Earnings (TTM)CN¥549.94m
Revenue (TTM)CN¥2.72b

1.7x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
C8R income statement (TTM)
RevenueCN¥2.72b
Cost of RevenueCN¥1.77b
Gross ProfitCN¥948.27m
Other ExpensesCN¥398.33m
EarningsCN¥549.94m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.28
Gross Margin34.91%
Net Profit Margin20.25%
Debt/Equity Ratio24.7%

How did C8R perform over the long term?

See historical performance and comparison

Dividends

9.0%

Current Dividend Yield

2%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is C8R undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for C8R?

Other financial metrics that can be useful for relative valuation.

C8R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.04x
Enterprise Value/EBITDA0.1x
PEG Ratio-0.1x

Price to Earnings Ratio vs Peers

How does C8R's PE Ratio compare to its peers?

C8R PE Ratio vs Peers
The above table shows the PE ratio for C8R vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average23.4x
5VJ Halcyon Agri
59.1xn/aS$342.9m
QES China Sunsine Chemical Holdings
3.4x-3.4%S$460.6m
C05 Chemical Industries (Far East)
7.5xn/aS$51.3m
MZH Nanofilm Technologies International
23.7x16.5%S$1.5b
C8R Jiutian Chemical Group
1.7x-13.9%S$186.9m

Price-To-Earnings vs Peers: C8R is good value based on its Price-To-Earnings Ratio (1.7x) compared to the peer average (23.4x).


Price to Earnings Ratio vs Industry

How does C8R's PE Ratio compare vs other companies in the Asian Chemicals Industry?

Price-To-Earnings vs Industry: C8R is good value based on its Price-To-Earnings Ratio (1.7x) compared to the SG Chemicals industry average (10x)


Price to Earnings Ratio vs Fair Ratio

What is C8R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

C8R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio1.7x
Fair PE Ratio4.4x

Price-To-Earnings vs Fair Ratio: C8R is good value based on its Price-To-Earnings Ratio (1.7x) compared to the estimated Fair Price-To-Earnings Ratio (4.4x).


Share Price vs Fair Value

What is the Fair Price of C8R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: C8R (SGD0.09) is trading below our estimate of fair value (SGD0.46)

Significantly Below Fair Value: C8R is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies

Future Growth

How is Jiutian Chemical Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-13.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: C8R's earnings are forecast to decline over the next 3 years (-13.9% per year).

Earnings vs Market: C8R's earnings are forecast to decline over the next 3 years (-13.9% per year).

High Growth Earnings: C8R's earnings are forecast to decline over the next 3 years.

Revenue vs Market: C8R's revenue is expected to decline over the next 3 years (-11.7% per year).

High Growth Revenue: C8R's revenue is forecast to decline over the next 3 years (-11.7% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: C8R's Return on Equity is forecast to be high in 3 years time (26.5%)


Discover growth companies

Past Performance

How has Jiutian Chemical Group performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


43.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: C8R has high quality earnings.

Growing Profit Margin: C8R's current net profit margins (20.2%) are higher than last year (19.2%).


Past Earnings Growth Analysis

Earnings Trend: C8R's earnings have grown significantly by 43.7% per year over the past 5 years.

Accelerating Growth: C8R's earnings growth over the past year (84.1%) exceeds its 5-year average (43.7% per year).

Earnings vs Industry: C8R earnings growth over the past year (84.1%) exceeded the Chemicals industry 24.7%.


Return on Equity

High ROE: C8R's Return on Equity (49.3%) is considered outstanding.


Discover strong past performing companies

Financial Health

How is Jiutian Chemical Group's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: C8R's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥981.5M).

Long Term Liabilities: C8R's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥58.7M).


Debt to Equity History and Analysis

Debt Level: C8R has more cash than its total debt.

Reducing Debt: C8R's debt to equity ratio has increased from 15.6% to 24.7% over the past 5 years.

Debt Coverage: C8R's debt is well covered by operating cash flow (263.1%).

Interest Coverage: C8R earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Jiutian Chemical Group current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


8.99%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: C8R's dividend (8.99%) is higher than the bottom 25% of dividend payers in the SG market (2.26%).

High Dividend: C8R's dividend (8.99%) is in the top 25% of dividend payers in the SG market (6.02%)


Stability and Growth of Payments

Stable Dividend: Too early to tell whether C8R's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if C8R's dividend payments are increasing as they only just started paying a dividend.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (1.8%), C8R's dividend payments are thoroughly covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (11.7%), C8R's dividend payments are thoroughly covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

5.0yrs

Average management tenure


CEO

Hongguang Wei

3.75yrs

Tenure

Mr. Hongguang Wei has been an Acting Chief Executive Officer at Jiutian Chemical Group Ltd since November 22, 2018. He serves as General Manager of subsidiaries at Jiutian Chemical Group Ltd in May 2017. H...


Leadership Team

Experienced Management: C8R's management team is seasoned and experienced (5 years average tenure).


Board Members

Experienced Board: C8R's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Jiutian Chemical Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Jiutian Chemical Group Limited
  • Ticker: C8R
  • Exchange: Catalist
  • Founded: 1994
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Implied Market Cap: S$186.914m
  • Shares outstanding: 1.99b
  • Website: https://www.uxasite.com

Location

  • Jiutian Chemical Group Limited
  • 350 Orchard Road
  • No. 21-03 Shaw house
  • Singapore
  • 238868
  • Singapore

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/14 00:00
End of Day Share Price2022/08/12 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.